Skip to main content
Clinical Trials/CTRI/2010/091/003044
CTRI/2010/091/003044
Recruiting
Phase 4

Comparison of the safety and effectiveness of dexmedetomidine with a combination of midazolam and fentanyl for sedation during awake fibreoptic nasotracheal intubation - A prospective, randomized, double-blind study

Anitha Shenoy0 sites30 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Patients who are scheduled to undergo surgery and require awake nasal fibreoptic intubation in view of anticipated difficult oral intubation
Sponsor
Anitha Shenoy
Enrollment
30
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Anitha Shenoy

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria : Patients of either gender aged above 18 years requiring awake nasal fibreoptic intubation

Exclusion Criteria

  • Exclusion Criteria:
  • Patients with ASA physical status IV, raised intracranial pressure, uncontrolled seizure disorder / known psychiatric illness, receiving \&\#945;2 agonists/antagonists in the past two weeks, where either dexmedetomidine or benzodiazepine administration is contra\-indicated and patients with acute unstable angina, laboratory confirmed acute myocardial infarction within the past 6 weeks, heart rate \<50bpm, systolic blood pressure \<90 mmHg, or complete heart block unless they have a pacemaker, patients with elevated liver enzymes \> 2 times normal

Outcomes

Primary Outcomes

Not specified

Similar Trials